Cargando…
Quality improvement project to enhance heparin safety in patients with haemodialysis in China
Autores principales: | Tan, Qiu-zhen, Mai, Yan-fen, Jiao, Hai-hong, Xiong, Ren-jie, Liu, Yu, Lin, Li, Cui, Li-wen, Pai, Pearl |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8996018/ https://www.ncbi.nlm.nih.gov/pubmed/35393293 http://dx.doi.org/10.1136/bmjoq-2021-001665 |
Ejemplares similares
-
Low-molecular weight heparin infusion as anticoagulation for haemodialysis
por: Wong, Steve Siu-Man, et al.
Publicado: (2016) -
Renal unit practitioners’ knowledge, attitudes and practice regarding the safety of unfractionated heparin for chronic haemodialysis
por: Ockhuis, Debra, et al.
Publicado: (2015) -
Bovine and porcine heparins: different drugs with similar effects on human haemodialysis
por: Tovar, Ana MF, et al.
Publicado: (2013) -
Estimation of Quality of Life in Haemodialysis Patients
por: Abraham, S., et al.
Publicado: (2012) -
Association of anti-HCV sero-prevalence with blood transfusion and practice of haemodialysis from multiple centres in patients on maintenance haemodialysis
por: Amjad, Umbreen, et al.
Publicado: (2020)